BIOMAT Database Logo BIOMAT Database Logo

Intramuscular compared with intravenous ampicillin in the treatment of meningococcal meningitis. 1982

N I Girgis, and W Yassin, and J E Sippel, and Z Farid

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008585 Meningitis, Meningococcal A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Treatment of purulent meningitis with intravenous ampicillin.
January 1968, Paediatrica Indonesiana,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration.
February 1975, American journal of diseases of children (1960),
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Sulbactam/ampicillin in the treatment of epidemic meningococcal meningitis in northern Nigeria.
January 1988, Drugs,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
[Therapeutic failure of ampicillin during meningococcal meningitis].
November 1976, Annales de pediatrie,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Meningococcal meningitis. Comparison of ampicillin and combined sulphadimidine-penicillin G treatment.
January 1969, Scandinavian journal of infectious diseases,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis.
January 1988, Scandinavian journal of infectious diseases,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Ceftriaxone alone compared to ampicillin and chloramphenicol in the treatment of bacterial meningitis.
January 1988, Chemotherapy,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis.
October 1991, Lancet (London, England),
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Treatment of Meningitis with Meningococcal Antitoxin.
April 1937, British medical journal,
N I Girgis, and W Yassin, and J E Sippel, and Z Farid
Ceftriaxone compared with a combination of ampicillin and chloramphenicol in the treatment of bacterial meningitis in adults.
January 1987, Drugs under experimental and clinical research,
Copied contents to your clipboard!